New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion
- PMID: 36913170
- DOI: 10.1007/s11883-023-01095-1
New CRISPR Technology for Creating Cell Models of Lipoprotein Assembly and Secretion
Abstract
Purpose of review: This review is aimed at providing an overview of new developments in gene editing technology, including examples of how this technology has been used to develop cell models for studying the effects of gene ablation or missense mutations on lipoprotein assembly and secretion.
Recent findings: CRISPR/Cas9-mediated gene editing is superior to other technologies because of its ease, sensitivity, and low off-target effects. This technology has been used to study the importance of microsomal triglyceride transfer protein in the assembly and secretion of apolipoprotein B-containing lipoproteins, as well as to establish causal effects of APOB gene missense mutations on lipoprotein assembly and secretion. CRISPR/Cas9 technology is anticipated to provide unprecedented flexibility in studying protein structure and function in cells and animals and to yield mechanistic insights into variants in the human genome.
Keywords: CRISPR; Cas9; Gene editing; Lipoproteins; Missense mutations.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step.J Biol Chem. 1996 Dec 20;271(51):33047-53. doi: 10.1074/jbc.271.51.33047. J Biol Chem. 1996. PMID: 8955151
-
Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells.J Lipid Res. 2010 Aug;51(8):2253-64. doi: 10.1194/jlr.M005371. Epub 2010 Feb 24. J Lipid Res. 2010. PMID: 20181985 Free PMC article.
-
Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.Am J Physiol Gastrointest Liver Physiol. 2003 Oct;285(4):G735-46. doi: 10.1152/ajpgi.00202.2003. Epub 2003 Jun 19. Am J Physiol Gastrointest Liver Physiol. 2003. PMID: 12816761
-
Inhibition of the synthesis of apolipoprotein B-containing lipoproteins.Handb Exp Pharmacol. 2005;(170):483-517. doi: 10.1007/3-540-27661-0_18. Handb Exp Pharmacol. 2005. PMID: 16596812 Review.
-
APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.Annu Rev Nutr. 2000;20:169-93. doi: 10.1146/annurev.nutr.20.1.169. Annu Rev Nutr. 2000. PMID: 10940331 Review.
Cited by
-
A suite of genome-engineered hepatic cells provides novel insights into the spatiotemporal metabolism of apolipoprotein B and apolipoprotein B-containing lipoprotein secretion.Cardiovasc Res. 2024 Sep 21;120(11):1253-1264. doi: 10.1093/cvr/cvae121. Cardiovasc Res. 2024. PMID: 38833612 Free PMC article.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
-
- Holliday R, Jeggo PA. Mechanisms for changing gene expression and their possible relationship to carcinogenesis. Cancer Surv. 1985;4(3):557–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous